LEADER 00939nam0-22003011i-450- 001 990003074080403321 035 $a000307408 035 $aFED01000307408 035 $a(Aleph)000307408FED01 035 $a000307408 100 $a20000920d1971----km-y0itay50------ba 101 0 $aeng 102 $aIT 200 1 $aEuropean Monetary Unification for Balanced Growth$eA New Approach$fGiovanni Magnifico. 210 $aPrinceton$dN.J.$cInternational Finance Section$dDepartment of Economics$dPrinceton University$d\August \\1971. 215 $a46 p.$d21 cm 225 1 $aEssays in international finance$v88 676 $aO/1.2430 676 $aO/2.43 702 1$aMagnifico,$bGiovanni 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990003074080403321 952 $aA/71 ESS$b6864 m/I$fSES 959 $aSES 996 $aEuropean Monetary Unification for Balanced Growth$9464650 997 $aUNINA DB $aING01 LEADER 01459cam0-22004211i-450 001 990005796200403321 005 20181210112924.0 035 $a000579620 035 $aFED01000579620 035 $a(Aleph)000579620FED01 035 $a000579620 100 $a19990604d1960----km-y0itay50------ba 101 1 $aita$cger 102 $aIT 105 $ay-------001yy 200 1 $aElementi plautini in Plauto$d=Plautinisches im Plautus$fEduard Fraenkel 210 $aFirenze$cLa nuova Italia$d1960 215 $aX, 463 p.$d26 cm 225 1 $a<>pensiero storico$v41 305 $aEd. orig.: Berlin, Weidmannsche Buchhandlung, 1922 307 $aRilegato con copertina rigida telata 454 0$12001$aPlautinisches im Plautus$916207 610 0 $aPlauto, Tito Maccio$aOpere 676 $a870.01$v20 700 1$aFraenkel,$bEduard$f<1888-1970>$0170035 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990005796200403321 952 $aDDR-Fonti II- Plautus St. 3$b28 ddr$fDDR$m21-4456 952 $aP2B-650-PLAUT.-8F.E.-1960$bIst.Fil.cl. 150$fFLFBC$m10-70859 952 $aP2B-650-PLAUT.-8F.E.-1960 bis$bIst.Fil.cl. 3688$fFLFBC$m10-61107 952 $aP2B-650-PLAUT.-8F.E.-1960 ter$bIst.Fil.cl. 4322$fFLFBC$m10-61108 952 $aP2B-650-PLAUT.-8F.E.-1960 quater$bBibl. 34759$fFLFBC$mBRAU-34573 959 $aFLFBC 959 $aDDR 959 $aFLFBC 996 $aPlautinisches im Plautus$916207 997 $aUNINA LEADER 05061nam 2201321z- 450 001 9910367745903321 005 20231214133007.0 010 $a3-03921-707-0 035 $a(CKB)4100000010106258 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/51774 035 $a(EXLCZ)994100000010106258 100 $a20202102d2019 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aLinks between Fibrogenesis and Cancer: Mechanistic and Therapeutic Challenges: Mechanistic and Therapeutic Challenges 210 $cMDPI - Multidisciplinary Digital Publishing Institute$d2019 215 $a1 electronic resource (348 p.) 311 $a3-03921-706-2 330 $aTissue fibrosis may occur for unknown causes or be the consequence of many pathological conditions including chronic inflammatory or infectious diseases, autoimmune disorders, graft rejection, or malignancy. On the other hand, malignant tumors have been identified in fibrotic tissues decades ago, and now accumulating evidence suggests that fibrotic lesions enhance the risk of cancer in several organs such as liver, lungs, and breast. Disruption of an organ parenchymal cells and of its normal structural scaffold during tissue fibrogenesis appears to induce loss of cell polarity, promoting uncontrolled cell proliferation that may eventually lead to cancer development. Many cellular and molecular abnormalities including aberrant expression of microRNAs, genetic and epigenetic alterations, evasion or delayed apoptosis, unregulated intracellular signal pathways, and dysregulation or defective intercellular communications have been proposed to explain this link between fibrogenesis and carcinogenesis. However, the precise mechanisms of this fibrosis-to-cancer transition remain unclear. This book presents a collection of reviews and original articles summarizing recent advances in understanding the molecular mechanisms of cancer development in fibrotic organs. 517 $aLinks between Fibrogenesis and Cancer 610 $ableomycin 610 $aregeneration 610 $aantitumor efficacy 610 $alung cancer 610 $aSOX2 610 $aleiomyosarcoma 610 $alung cancer (LC) 610 $ananoparticles 610 $acytokines 610 $ahepatocellular carcinoma 610 $ametabolic reprogramming 610 $ahepatic stellate cells 610 $aangiogenesis 610 $atransforming growth factor-? 610 $aanaplastic lymphoma kinase 610 $aidiopathic pulmonary fibrosis 610 $agrowth factor 610 $apathogenesis 610 $acancer-associated fibroblasts 610 $afibrosis 610 $alipopolysaccharide 610 $aDHA 610 $alncRNA 610 $aSREBP-1 610 $aYAP 610 $aprotein S 610 $anon-small cell lung cancer (NSCLC) 610 $aomega-3 fatty acid 610 $ainflammation 610 $ametastasis 610 $aclinical symptoms 610 $amiRNA 610 $asmooth muscle tumor of uncertain malignant potential 610 $aWnt 610 $ainterstitial fluid pressure 610 $aheterogeneity 610 $ahepatocytes 610 $amyometrium 610 $atumor necrosis factor ? 610 $atumor 610 $atumor microenvironment 610 $aextracellular matrix 610 $aTAZ 610 $acarcinogenesis 610 $acystic formation 610 $apulmonary fibrosis 610 $aHBV 610 $acytokine 610 $agenetic instability 610 $adiagnosis 610 $aEMT 610 $acrizotinib 610 $aHippo pathway 610 $aGPR120 610 $amarker 610 $aHCV 610 $anon-alcoholic steatohepatitis 610 $apathology 610 $acommon pathways 610 $aapoptosis 610 $atype I collagen 610 $aGPR40 610 $aacute lung injury 610 $auterine fibroid 610 $arenal injury 610 $apathophysiology 610 $areactive oxygen species 610 $aimmunohistochemistry 610 $aSMAD 610 $abutylidenephthalide 610 $aleiomyoma 610 $acirrhosis 610 $aErk1/2 610 $atargeted therapy 610 $aTGF-? 610 $amechanotransduction 610 $atherapy 610 $abreast cancer 610 $ahepatocellular carcinoma (HCC) 610 $ahepatic stellate cells (HSCs) 610 $aidiopathic pulmonary fibrosis (IPF) 610 $acancer-associated fibroblasts (CAFs) 610 $acancer 610 $asignal pathway 610 $atumor stiffness 700 $aGabazza$b Esteban C$4auth$01288168 906 $aBOOK 912 $a9910367745903321 996 $aLinks between Fibrogenesis and Cancer: Mechanistic and Therapeutic Challenges: Mechanistic and Therapeutic Challenges$93020666 997 $aUNINA